Jiang Y, Shen Y. Composite dietary antioxidant index is inversely and nonlinearly associated with cardiovascular disease, atherosclerotic cardiovascular disease, and cardiovascular mortality in people with dyslipidemia: evidence from NHANES 2001–2018. Front Nutr. 2024. https://doi.org/10.3389/fnut.2024.1478825.

Article  PubMed  PubMed Central  Google Scholar 

Grundy SM. Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy. Am J Cardiol. 1995;75(6):45. https://doi.org/10.1016/0002-9149(95)80011-g. B-52B.

Article  Google Scholar 

Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 1990;82(2):495–506. https://doi.org/10.1161/01.cir.82.2.495.

Article  PubMed  CAS  Google Scholar 

Maki KC, Benes L, Dicklin MR. Pathophysiology and management of dyslipidemias associated with insulin-resistant States. In: Davidson MH, Toth PP, Maki KC, editors. Therapeutic lipidology. Contemporary cardiology. Cham: Humana; 2021. https://doi.org/10.1007/978-3-030-56514-5_16.

Chapter  Google Scholar 

Wang C, Zheng M, Chen S, Wu S, Xue H. Association of inflammation and atherogenic dyslipidemia with incident cardiometabolic disease: a longitudinal cohort study. J Hypertens. 2024;42(Suppl 1):e269. https://doi.org/10.1097/01.hjh.0001022264.98015.4d.

Article  Google Scholar 

Siri-Tarino PW, Woods AC, Bray GA, Krauss RM. Reversal of small, dense LDL subclass phenotype by weight loss is associated with impaired fat oxidation. Obesity. 2011;19(1):61–8. https://doi.org/10.1038/oby.2010.142.

Article  PubMed  Google Scholar 

Faghihnia N, Siri-Tarino PW, Krauss RM, Brooks GA. Energy substrate partitioning and efficiency in individuals with atherogenic lipoprotein phenotype. Obesity. 2011;19(7):1360–5. https://doi.org/10.1038/oby.2011.72.

Article  PubMed  CAS  Google Scholar 

Astrup A, Buemann B, Christensen NJ, Toubro S. Failure to increase lipid oxidation in response to increasing dietary fat content in formerly obese women. Am J Physiol. 1994;266(4 Pt 1):E592-599.

PubMed  CAS  Google Scholar 

Blaak EE, Hul G, Verdich C, Stich V, Martinez A, Petersen M, et al. Fat oxidation before and after a high fat load in the obese insulin-resistant state. J Clin Endocrinol Metab. 2006;91(4):1462–9. https://doi.org/10.1210/jc.2005-1598.

Article  PubMed  CAS  Google Scholar 

Zhou Z, Parra-Soto S, Boonpor J, Petermann-Rocha F, Welsh P, Mark PB, et al. Exploring the underlying mechanisms linking adiposity and cardiovascular disease: a prospective cohort study of 404,332 UK biobank participants. Curr Probl Cardiol. 2023;48(8): 101715. https://doi.org/10.1016/j.cpcardiol.2023.101715.

Article  PubMed  Google Scholar 

Gellert KS, Keil AP, Zeng D, Lesko CR, Aubert RE, Avery CL, et al. Reducing the population burden of coronary heart disease by modifying adiposity: estimates from the ARIC study. J Am Heart Assoc. 2020;9(4): e012214. https://doi.org/10.1161/JAHA.119.012214.

Article  PubMed  PubMed Central  Google Scholar 

Huang H, Liu J, Liang X, Fang L, Yang C, Ke K, et al. Trends in the prevalence of elevated cardiovascular risk and the control of its risk factors among US adults, 2001–2020. Front Cardiovasc Med. 2023;10: 1153926. https://doi.org/10.3389/fcvm.2023.1153926.

Article  PubMed  PubMed Central  Google Scholar 

Fan W, Wong ND. Epidemiology, control, and cardiovascular outcomes of dyslipidemia in diabetes. In: Jenkins AJ, Toth PP, editors. Lipoproteins in diabetes mellitus. Cham: Humana; 2023. [Chapter 32]. (Contemporary Diabetes). https://doi.org/10.1007/978-3-031-26681-2_32.

Chapter  Google Scholar 

van Zwol W, van de Sluis B, Ginsberg HN, Kuivenhoven JA. VLDL biogenesis and secretion: it takes a village. Circ Res. 2024;134(2):226–44. https://doi.org/10.1161/CIRCRESAHA.123.323284.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Krauss RM, Lu JT, Higgins JJ, Clary CM, Tabibiazar R. VLDL receptor gene therapy for reducing atherogenic lipoproteins. Mol Metab. 2023;69: 101685. https://doi.org/10.1016/j.molmet.2023.101685.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev. 2002;23(2):201–29. https://doi.org/10.1210/edrv.23.2.0461.

Article  PubMed  CAS  Google Scholar 

Krauss RM, King SM. Remnant lipoprotein particles and cardiovascular disease risk. Best Pract Res Clin Endocrinol Metab. 2023;37(3): 101682. https://doi.org/10.1016/j.beem.2022.101682.

Article  PubMed  CAS  Google Scholar 

Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002;43(9):1363–79.

Article  PubMed  CAS  Google Scholar 

Sousa F, Mendonca M, Sa D, Abreu G, Henriques E, Freitas S, et al. The change of paradigm: high HDL-c levels could not mean a long lifespan. Eur Heart J. 2024;45(Supplement1): ehae666.2739. https://doi.org/10.1093/eurheartj/ehae666.2739.

Article  Google Scholar 

Razavi AC, Jain V, Grandhi GR, et al. Does elevated high-density lipoprotein cholesterol protect against cardiovascular disease? J Clin Endocrinol Metab. 2024;109(2):321–32. https://doi.org/10.1210/clinem/dgad406.

Article  PubMed  CAS  Google Scholar 

Black DM, Miller M, Heinonen TM, Zhang G. Advancing beyond failed high-density lipoprotein clinical trials to pharmacogenetic studies of ADCY9 and cholesterol ester transfer protein inhibition. J Cardiovasc Pharmacol. 2021;78(4):496–500. https://doi.org/10.1097/FJC.0000000000001093.

Article  PubMed  CAS  Google Scholar 

Pirillo A, Catapano AL. Increasing high-density lipoprotein cholesterol levels for cardiovascular benefit: the end of a dream? Eur J Prev Cardiol. 2019;26(5):531–2. https://doi.org/10.1177/2047487318820976.

Article  PubMed  Google Scholar 

Chen XF, Xiang YF, Cai XL, Chen JH, Lin XQ, Lin BT, et al. A v-shaped association between high-density lipoprotein cholesterol levels and poor outcomes in patients after percutaneous coronary intervention. Int J Cardiol. 2024;400: 131773. https://doi.org/10.1016/j.ijcard.2024.131773.

Article  PubMed  Google Scholar 

Krauss RM. Small dense low-density lipoprotein particles: clinically relevant? Curr Opin Lipidol. 2022;33(3):160–6. https://doi.org/10.1097/MOL.0000000000000824.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients. Curr Atheroscler Rep. 2010;12(6):384–90. https://doi.org/10.1007/s11883-010-0131-6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119(5):1322–34. https://doi.org/10.1172/JCI37385.

Article  PubMed  PubMed Central  CAS  Google Scholar 

González AP, Flores-Ramírez A, Gutiérrez-Castro KP, Luévano-Contreras C, Gómez-Ojeda A, Sosa-Bustamante GP, et al. Reduction of small dense LDL and Il-6 after intervention with Plantago psyllium in adolescents with obesity: a parallel, double blind, randomized clinical trial. Eur J Pediatr. 2021;180(8):2493–503. https://doi.org/10.1007/s00431-021-04064-5.

Article  PubMed  CAS  Google Scholar 

Bergeron N, Chiu S, Williams PT, King M, Krauss S. Effects of red meat, white meat, and nonmeat protein sources on atherogenic lipoprotein measures in the context of low compared with high saturated fat intake: a randomized controlled trial. Am J Clin Nutr. 2019;110(1):24. https://doi.org/10.1093/ajcn/nqz035.

Article  PubMed  PubMed Central  Google Scholar 

Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia2. Am J Clin Nutr. 2006;83(5):1025–31. https://doi.org/10.1093/ajcn/83.5.1025.

Article  PubMed